From: Angiogenesis in cancer of unknown primary: clinicopathological study of CD34, VEGF and TSP-1
Subgroups | (#) | (%) |
---|---|---|
Favorable | 50 | 62 |
Unfavorable | 31 | 38 |
Treatment | (#) | (%) |
Chemotherapy | 64 | 78 |
Radiotherapy | 4 | 6 |
Median survival | (months) | |
All cases | 10.5 | |
favourable cases | 11.5 | |
unfavorable cases | 8.5 |